New Aspects of the Treatment of Patients with Low-Risk Myelodysplastic Syndromes

Autor:	Dieter Hoelzer, U. Kalina, W.-K. Hofmann, G. Seipelt
Rok vydání:	2000
Předmět:	Oncology Ineffective Hematopoiesis Cancer Research medicine.medical_specialty business.industry Myelodysplastic syndromes Hematology medicine.disease Acute Myelogenous Leukemias hemic and lymphatic diseases Internal medicine medicine Intensive care medicine business neoplasms
Zdroj:	Oncology Research and Treatment. 23:12-16
ISSN:	2296-5262 2296-5270
DOI:	10.1159/000027062
Popis:	SummaryMyelodysplastic syndromes (MDS) are characterized initially by ineffective hematopoiesis and subsequently the frequent development of acute myelogenous leukemias (AML). During the
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c2c717bc0b6aa9f0f47f5b0db42e3163 https://doi.org/10.1159/000027062 Zobrazit plný text záznamu